Background: Anti-SARS-CoV-2 virus antibody levels in convalescent plasma (CP), which
may be useful in severe Anti-SARS-CoV-2 virus infections, have been rarely reported …

Background Monocytes and macrophages play a pivotal role in inflammation during acute
SARS-CoV-2 infection. However, their contribution to the development of post-acute …

Introduction At the end of 2019, Wuhan, a city in China with a population of about 11 million,
witnessed the outbreak of unusual pneumonia. As of 29 March 2020, the disease has …

Currently, few evidences have shown the possible involvement of autoimmunity in patients
affected by coronavirus disease 2019 (COVID‐19). In this study, we elucidate whether …

Rationale: Coronavirus disease (COVID-19) is a global threat to health. Its inflammatory
characteristics are incompletely understood. Objectives: To define the cytokine profile of …

Aims The immune response is essential for the control and resolution of viral infections.
Following the outbreak of novel coronavirus disease (COVID-19), several immunotherapies …

Abstract COVID-19 is associated with 5.1% mortality. Although the virological,
epidemiological, clinical, and management outcome features of COVID-19 patients have …

Introduction: The outbreak of novel coronavirus COVID-19 infections that started in China
late 2019 has spread rapidly and cases have been recorded worldwide. So, in this study, we …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), emerged in late 2019 and has since become a …

Transfer of convalescent plasma (CP) had been proposed early during the SARS-CoV-2
pandemic as an accessible therapy, yet trial results worldwide have been mixed, potentially …